MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 4 filers reported holding MANNKIND CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $87,000 | +31.8% | 137,608 | +29.3% | 0.00% | 0.0% |
| Q3 2016 | $66,000 | +22.2% | 106,430 | +133.6% | 0.00% | 0.0% |
| Q2 2016 | $54,000 | -28.9% | 45,560 | -3.2% | 0.00% | 0.0% |
| Q1 2016 | $76,000 | +18.8% | 47,060 | +6.8% | 0.00% | 0.0% |
| Q4 2015 | $64,000 | -54.6% | 44,060 | 0.0% | 0.00% | -66.7% |
| Q3 2015 | $141,000 | -48.5% | 44,060 | -8.7% | 0.00% | -40.0% |
| Q2 2015 | $274,000 | +11.4% | 48,280 | +2.2% | 0.01% | 0.0% |
| Q1 2015 | $246,000 | +40.6% | 47,230 | +40.8% | 0.01% | +25.0% |
| Q4 2014 | $175,000 | +76.8% | 33,555 | +100.8% | 0.00% | +33.3% |
| Q3 2014 | $99,000 | -38.1% | 16,710 | +14.6% | 0.00% | -25.0% |
| Q2 2014 | $160,000 | +105.1% | 14,575 | -25.2% | 0.00% | +100.0% |
| Q1 2014 | $78,000 | -11.4% | 19,475 | +14.7% | 0.00% | -33.3% |
| Q4 2013 | $88,000 | +4.8% | 16,975 | +15.9% | 0.00% | 0.0% |
| Q3 2013 | $84,000 | -21.5% | 14,650 | -10.7% | 0.00% | -25.0% |
| Q2 2013 | $107,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greywolf Capital Management LP | 7,206,570 | $37,582,000 | 6.66% |
| AYM CAPITAL, LLC | 1,417,300 | $7,392,000 | 5.50% |
| AYM CAPITAL, LLC | 655,000 | $3,416,000 | 2.54% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,810,250 | $9,440,000 | 2.51% |
| Beach Point Capital Management LP | 1,902,100 | $9,919,000 | 2.37% |
| Cohen Capital Management, Inc. | 503,000 | $2,623,000 | 0.68% |
| Tourbillon Capital Partners, L.P. | 3,300,000 | $17,210,000 | 0.46% |
| EQUITEC SPECIALISTS, LLC | 288,700 | $1,504,000 | 0.39% |
| Old West Investment Management, LLC | 116,676 | $608,000 | 0.38% |
| Adamant Biomedical Investments AG | 300,000 | $1,564,000 | 0.37% |